Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ TASP 0277308
GREENER_CHOICESDP

Catalog No. 64985 Shop All Novus Products
Change view
Click to view available options
Quantity:
5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
64-985 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 64-985 Supplier R&D Systems™ Supplier No. 6498/5

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Potent and selective S1P1 receptor antagonist; inhibits angiogenesis

TASP 0277308 is a potent and selective sphingosine 1-phosphate 1 (S1P1) receptor antagonist (IC50 = 7.8 nM). TASP 0277308 inhibits S1P-induced chemotaxis (IC50 = 1.1-1.6 nM), HUVEC cell proliferation (IC50 = 3-3.6 nM) and suppresses angiogenesis in vivo. TASP 0277308 also blocks VEGF-induced tube-formation of HUVECs in vitro and reverses or impairs the development of arthritis or mechano-allodynia.

Specifications

Chemical Name or Material 3,4-Dichloro-N-[(1 R)-1-[4-ethyl-5-[3-(4-methyl-1-piperazinyl)phenoxy]-4 H-1,2,4-triazol-3-yl]ethyl]benzenesulfonamide
CAS 945725-50-8
Quantity 5 mg
Product Line Tocris
Target Sphingosine-1-phosphate Receptor Antagonists
Molecular Formula C23H28Cl2N6O3S
Purity 0.98
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.